NM_000179.3(MSH6):c.964G>A (p.Ala322Thr) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Jun 1, 2022
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001525064.4

Allele description [Variation Report for NM_000179.3(MSH6):c.964G>A (p.Ala322Thr)]

NM_000179.3(MSH6):c.964G>A (p.Ala322Thr)

Gene:

MSH6:mutS homolog 6 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2p16.3

Genomic location:

Preferred name:

NM_000179.3(MSH6):c.964G>A (p.Ala322Thr)

HGVS:

NC_000002.12:g.47798947G>A
NG_007111.1:g.20801G>A
NM_000179.3:c.964G>AMANE SELECT
NM_001281492.2:c.574G>A
NM_001281493.2:c.58G>A
NM_001281494.2:c.58G>A
NP_000170.1:p.Ala322Thr
NP_001268421.1:p.Ala192Thr
NP_001268422.1:p.Ala20Thr
NP_001268423.1:p.Ala20Thr
LRG_219t1:c.964G>A
LRG_219:g.20801G>A
NC_000002.11:g.48026086G>A
NM_000179.2:c.964G>A

Protein change:

A192T

Links:

dbSNP: rs772126419

NCBI 1000 Genomes Browser:

rs772126419

Molecular consequence:

NM_000179.3:c.964G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001281492.2:c.574G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001281493.2:c.58G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001281494.2:c.58G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

esv3644276 (1)
dbVar
hypothetical protein SDJN03_12140, partial [Cucurbita argyrosperma subsp. sorori...
hypothetical protein SDJN03_12140, partial [Cucurbita argyrosperma subsp. sororia]
gi|2047924345|gb|KAG6595587.1||gnl| AGKQH|SDJN03_12140

Protein
hypothetical protein CSA_017844, partial [Cucumis sativus]
hypothetical protein CSA_017844, partial [Cucumis sativus]
gi|1775807376|gb|KAE8637567.1||gnl| CHR|CsaV3_UNP186410.1.cds1

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001735067	Color Diagnostics, LLC DBA Color Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain significance (Jun 8, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV002693866	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jun 1, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001735067

Color Diagnostics, LLC DBA Color Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain significance
(Jun 8, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002693866

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jun 1, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV001735067.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This missense variant replaces alanine with threonine at codon 322 of the MSH6 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 1/251356 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Ambry Genetics, SCV002693866.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.A322T variant (also known as c.964G>A), located in coding exon 4 of the MSH6 gene, results from a G to A substitution at nucleotide position 964. The alanine at codon 322 is replaced by threonine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine